Author

Sara Llorente-Armijo

Hospital Universitario La Paz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Alberto Manuel BorobiaiD· 1 shared Ana JanevaiD· 1 shared Andrea Zapater‐MorosiD· 1 shared Angelo Gámez‐PozoiD· 1 shared Axel ImhofiD· 1 shared Christopher A. PenfoldiD· 1 shared Enrique EspinosaiD· 1 shared Eva HörmansederiD· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Alberto Manuel BorobiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Digital Reprogramming Decodes Epigenetic Barriers of Cell Fate Changes

Ana Janeva, Christopher A. Penfold, Sara Llorente-Armijo, Huiwen Li, Tomáš Zikmund, Marco Stock, Jérôme Jullien, Tobias Straub, Ignasi Forné, Axel Imhof, Juan M. Vaquerizas, John Bertrand Gurdon, Eva Hörmanseder

This study identifies H3K27ac as an epigenetic barrier to reprogramming-induced cell fate changes using an AI-based approach and shows that reducing H3K27ac improves reprogramming efficiency.

bioRxiv · Jan 22, 2025 · PreprintGenomics

Molecular characterization of breast cancer cell response to metabolic drugs

Lucía Trilla‐Fuertes, Angelo Gámez‐Pozo, Jorge M. Arevalillo, Mariana Díaz‐Almirón, Guillermo Prado-Vázquez, Andrea Zapater‐Moros, Hilario Navarro, Rosa Aras‐López, Irene Dapía, Rocío López‐Vacas, Paolo Nanni, Sara Llorente-Armijo, Pedro Arias, Alberto Manuel Borobia, Paloma Maı́n, , Juan Ángel Fresno Vara

The paper characterizes breast cancer cell responses to metabolic drugs using proteomics and computational models, showing heterogeneous effects and pathway-level flux changes.

Oncotarget · Jan 8, 2018Peer-reviewedSystems Biology